Evidence map›Paper›PMID 23163855›Full record

ArticleNutrition and cancer2012

Effects of Tepary bean (Phaseolus acutifolius) protease inhibitor and semipure lectin fractions on cancer cells.

Teresa García-Gasca, Marlen García-Cruz, Elisa Hernandez-Rivera, Josue López-Matínez, Ana L Castañeda-Cuevas, Lorena Yllescas-Gasca, Adriana J Rodríguez-Méndez, Elizabeth Mendiola-Olaya, José L Castro-Guillén, Alejandro Blanco-Labra

Abstract read
In one paragraph

Article in Nutrition and cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Purification, Characterization and Bioactivity of a New Homodimeric Lectin FromPlant-environment interactions (Hoboken, N.J.) · 2025
    Article
  2. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Tepary Bean (International journal of molecular sciences · 2025
    Article
  4. Review
  5. EGFR and p38Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Bioaccessibility andInternational journal of molecular sciences · 2021
    Article
  10. Protein Concentrates on Tepary Bean (Frontiers in nutrition · 2021
    Article
  11. Tepary bean (Toxicology research · 2020
    Article
  12. Article
  13. Quantum Dot Labelling of Tepary Bean (Molecules (Basel, Switzerland) · 2020
    Article
  14. Tepary Bean (Molecules (Basel, Switzerland) · 2020
    Article
  15. Article
  16. Article
  17. Plant Lectins as Medical Tools against Digestive System Cancers.International journal of molecular sciences · 2017
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Teresa García-GascaFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Querétaro, México. tggasca@gmail.com
Marlen García-Cruz
Elisa Hernandez-Rivera
Josue López-Matínez
Ana L Castañeda-Cuevas
Lorena Yllescas-Gasca
Adriana J Rodríguez-Méndez
Elizabeth Mendiola-Olaya
José L Castro-Guillén
Alejandro Blanco-Labra

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some natural and synthetic protease inhibitors (PI), such as the Bowman-Birk PI from soybean, have anticancer effects. We previously purified and characterized a Bowman-Birk-type PI from Tepary bean (Phaseolus acutifolius) seeds (TBPI). A semipure protein fraction containing this inhibitor, when tested its in vitro effect on transformed cells, showed a differential cytotoxic effect, as well as an increase in cell attachment to culture dishes. In this article we report that lectins were responsible for the cytotoxic effect previously observed, exhibiting a differential, antiproliferative effect on nontransformed cells and on different lineages of cancer cells. Although the purified TBPI lacked cytotoxicity, it was found to be responsible for the increase in cell adhesion, decreasing culture dishes' extracellular matrix degradation, leading to a decrease of the in vitro cell invasion capacity. This effect coincided with the suppression of Matrix Metalloproteinase-9 activity. These results indicate that Tepary bean seeds contain at least 2 different groups of bioactive proteins with distinct effects on cancer cells.

Indexed as

3T3 CellsAnimalsCaco-2 CellsCell AdhesionCell Line, TumorCell ProliferationExtracellular MatrixHeLa CellsHumansLectinsMCF-7 CellsMiceNeoplasm InvasivenessPhaseolusProtease InhibitorsSeedsLectinsProtease Inhibitors

Identifiers

PMID23163855
PMCPMC3856472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.